These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3260398)

  • 1. Studies of autoimmunity in Graves' disease before and after treatment with carbimazole.
    Zosin I; Arcan P; Lungu G; Cotoi A; Opreanu R
    Endocrinologie; 1988; 26(1):49-53. PubMed ID: 3260398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.
    Charreire J; Karsenty G; Bouchard P; Schaison G
    Clin Exp Immunol; 1984 Sep; 57(3):633-8. PubMed ID: 6147216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission.
    Peakman M; Hussain M; Cundy T; Vergani D
    J Clin Lab Immunol; 1989 Sep; 30(1):1-5. PubMed ID: 2577115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
    Okabe N; Inoue K; Mori R
    J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide.
    Wilson R; McKillop JH; Pearson C; Burnett AK; Gunn I; McNicol AM; Thomson JA
    Clin Exp Immunol; 1988 Aug; 73(2):265-8. PubMed ID: 3263232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential immunosuppressive action of carbimazole and propylthiouracil.
    Wilson R; McKillop JH; Pearson C; Burnett AK; Thomson JA
    Clin Exp Immunol; 1988 Aug; 73(2):312-5. PubMed ID: 3263234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin autoantibodies in Graves' disease--before and after carbimazole therapy.
    Armitage M; Franklyn J; Scott-Morgan L; Parr J; Borsey DQ; Sheppard M; Wilkin TJ
    Diabetes Res Clin Pract; 1990 Mar; 8(3):169-76. PubMed ID: 2340791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T lymphocyte subsets at various stages of hyperthyroid Graves' disease: effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA status.
    Madec AM; Allannic H; Genetet N; Gueguen M; Genetet G; Fauchet R; Stefanutti A; Orgiazzi J
    J Clin Endocrinol Metab; 1986 Jan; 62(1):117-21. PubMed ID: 3484386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triiodothyronine antibodies in a case of Graves' disease: long-term follow-up under carbimazole.
    Heshmati HM; Izembart M; Turpin G; Vallée G
    Horm Metab Res; 1991 Mar; 23(3):148. PubMed ID: 1864563
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum immunoglobulin levels in thyroid disease.
    Glynne A; Thomson JA
    Clin Exp Immunol; 1972 Sep; 12(1):71-8. PubMed ID: 4628405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of recently activated, memory and naive lymphocyte T subsets in the peripheral blood of patients with Graves' disease and insulin-dependent diabetes mellitus.
    Kretowski A; Myśliwiec J; Turowski D; Wysocka J; Kinalska I
    Rocz Akad Med Bialymst; 1999; 44():226-34. PubMed ID: 10697437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.
    Modebe O
    Afr J Med Med Sci; 1995 Dec; 24(4):347-51. PubMed ID: 8886149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
    Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Asanuma K; Hama Y; Ito K; Maruyama M; Amano J
    Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of peripheral B lymphocytes in Graves' disease.
    Mori H; Amino N; Iwatani Y; Kabutomori O; Asari S; Motoi S; Miyai K; Kumahara Y
    Clin Exp Immunol; 1980 Oct; 42(1):33-40. PubMed ID: 6970099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrence of Graves-Basedow disease: the influence of treatment schedule].
    Goñi Iriarte MJ; Forga Llenas L; Iriarte Beroiz A; Apiñániz EA; Rodríguez Erdozain R; Menéndez Torre E
    Med Clin (Barc); 1995 Jan; 104(1):11-4. PubMed ID: 7877347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid antibodies are produced by thyroid-derived lymphocytes.
    Weetman AP; McGregor AM; Lazarus JH; Hall R
    Clin Exp Immunol; 1982 Apr; 48(1):196-200. PubMed ID: 7044629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No prognostic value of thyroid autoantibodies changes during and after methimazole therapy in patients with Graves' disease.
    Lattanzi V; Ciampolillo A; Vincenti C; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Apr; 61(4):507-13. PubMed ID: 3840026
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pedigrees of 110 patients with Graves' disease and the determinations of antithyroid antibodies in their first-degree relatives].
    Wang DQ; Wang JH; Ren JM
    Zhonghua Yi Xue Za Zhi; 1994 May; 74(5):303-5, 327. PubMed ID: 7953924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and significance of steatorrhea in patients with active Graves' disease.
    Goswami R; Tandon RK; Dudha A; Kochupillai N
    Am J Gastroenterol; 1998 Jul; 93(7):1122-5. PubMed ID: 9672342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.